Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

被引:29
|
作者
Aasen, Synnove Nymark [1 ,2 ]
Parajuli, Himalaya [1 ]
Tuyen Hoang [1 ]
Feng, Zichao [1 ,3 ]
Stokke, Krister [1 ]
Wang, Jiwei [1 ,3 ]
Roy, Kislay [1 ]
Bjerkvig, Rolf [1 ,4 ]
Knappskog, Stian [2 ,5 ]
Thorsen, Frits [1 ,4 ,6 ]
机构
[1] Univ Bergen, Kristian Gerhard Jebsen Brain Tumour Res Ctr, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway
[2] Haukeland Hosp, Dept Oncol & Med Phys, Jonas Lies Vei 65, N-5021 Bergen, Norway
[3] Shandong Univ, Brain Sci Res Inst, 44 Wenhuaxi Rd, Jinan 250100, Shandong, Peoples R China
[4] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg
[5] Univ Bergen, Sect Oncol, Dept Clin Sci, N-5020 Bergen, Norway
[6] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Jonas Lies Vei 91, N-5009 Bergen, Norway
关键词
melanoma; brain metastasis; BRAF; MAPK; PI3K; combined treatment; apoptosis; CANCER CELLS; ACQUIRED-RESISTANCE; BUPARLISIB BKM120; BRAIN METASTASIS; DOSE-ESCALATION; IN-VITRO; MEK; APOPTOSIS; EXPRESSION; SURVIVIN;
D O I
10.3390/ijms20174235
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant melanoma is the most aggressive type of skin cancer and is closely associated with the development of brain metastases. Despite aggressive treatment, the prognosis has traditionally been poor, necessitating improved therapies. In melanoma, the mitogen activated protein kinase and the phosphoinositide 3-kinase signaling pathways are commonly altered, and therapeutically inhibiting one of the pathways often upregulates the other, leading to resistance. Thus, combined treatment targeting both pathways is a promising strategy to overcome this. Here, we studied the in vitro and in vivo effects of the PI3K inhibitor buparlisib and the MEK1/2 inhibitor trametinib, used either as targeted monotherapies or in combination, on patient-derived melanoma brain metastasis cell lines. Scratch wound and trans-well assays were carried out to assess the migratory capacity of the cells upon drug treatment, whereas flow cytometry, apoptosis array and Western blots were used to study apoptosis. Finally, an in vivo treatment experiment was carried out on NOD/SCID mice. We show that combined therapy was more effective than monotherapy. Combined treatment also more effectively increased apoptosis, and inhibited tumor growth in vivo. This suggests a clinical potential of combined treatment to overcome ceased treatment activity which is often seen after monotherapies, and strongly encourages the evaluation of the treatment strategy on melanoma patients with brain metastases.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer
    Zhang, Wenyuan
    Zhou, Qing
    Wei, Yunhai
    Da, Miao
    Zhang, Chun
    Zhong, Jing
    Liu, Jin
    Shen, Junjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (07): : 2474 - 2484
  • [32] Oligomeric proanthocyanidin derived from grape seeds inhibited NFkB signaling in activated HSC: Involvement of JNK/ERK MAPK and PI3K/Akt pathways
    Jiang, Min
    Wu, Yan-Ling
    Li, Xia
    Zhang, Yu
    Xia, Kai-Li
    Cui, Ben-Wen
    Lian, Li-Hua
    Nan, Ji-Xing
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 674 - 680
  • [33] STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway
    Wang, Yang
    Lou, Nan
    Zuo, Min
    Zhu, Fuqiang
    He, Yan
    Cheng, Zhiqiang
    Wang, Xiaomei
    RNA BIOLOGY, 2021, 18 : 355 - 368
  • [34] Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
    Zarneshan, Seyede Nazanin
    Fakhri, Sajad
    Farzaei, Mohammad Hosein
    Khan, Haroon
    Saso, Luciano
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 145
  • [35] Targeting PI3K/AKT signaling pathway in obesity
    Savova, Martina S.
    Mihaylova, Liliya, V
    Tews, Daniel
    Wabitsch, Martin
    Georgiev, Milen I.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 159
  • [36] AR Signaling and the PI3K Pathway in Prostate Cancer
    Crumbaker, Megan
    Khoja, Leila
    Joshua, Anthony M.
    CANCERS, 2017, 9 (04):
  • [37] Role of PI3K/AKT Signaling Pathway in Nucleus Pulposus Cells
    Xiao, Quan
    Teng, Yun
    Xu, Changming
    Pan, Wei
    Yang, Hanshi
    Zhao, Jiali
    Zhou, Quan
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [38] BMP9 inhibits the growth of breast cancer cells by downregulation of the PI3K/Akt signaling pathway
    Li, Shu
    Dai, Hongying
    He, Yong
    Peng, Shusheng
    Zhu, Tianjin
    Wu, Yang
    Li, Chenwei
    Wang, Ke
    ONCOLOGY REPORTS, 2018, 40 (03) : 1743 - 1751
  • [39] Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway
    Wu, Yuehan
    Wang, Yapei
    Liu, Han
    Hu, Qiannan
    Xie, Yuqi
    Nan, Xiaoxu
    He, Huan
    Liu, Ying
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] The PI3K Pathway: Background and Treatment Approaches
    Lux, Michael P.
    Fasching, Peter A.
    Schrauder, Michael G.
    Hein, Alexander
    Jud, Sebastian M.
    Rauh, Claudia
    Beckmann, Matthias W.
    BREAST CARE, 2016, 11 (06) : 398 - 404